Searchable abstracts of presentations at key conferences in endocrinology

ea0099p402 | Late-Breaking | ECE2024

Gonadis national registry on gonadal status in pituitary and adrenal disorders: prevalence and characterization of testicular morpho-structural and reproductive alterations in male patients with congenital adrenal hyperplasia

Menafra Davide , Ferrari Davide , Rastrelli Giulia , de Angelis Cristina , Minnetti Marianna , Simeoli Chiara , Vignozzi Linda , Corona Giovanni , Isidori Andrea , Pivonello Rosario

Congenital adrenal hyperplasia (CAH) is a disorder due to mutations of genes coding for adrenal steroidogenesis enzymes, commonly caused by 21α-hydroxylase enzyme deficiency. Severe impairment of 21α-hydroxylase synthesis results in the classic form of CAH (c-CAH) characterized by cortisol and aldosterone deficiency (salt wasting form - SW), or partial enzyme deficiency characterized by cortisol deficiency (simple virilizing form - SV); mild impairment of 21α-hy...

ea0099p552 | Reproductive and Developmental Endocrinology | ECE2024

Hypoechoic testicular lesions in klinefelter syndrome show volumetric reduction in response to testosterone therapy

Ferrari Davide , Sesti Franz , Tenuta Marta , Carlomagno Francesco , Gianfrilli Daniele , Pozza Carlotta , Isidori Andrea

Introduction: Patients with Klinefelter Syndrome (KS) often display small, multiple, non-palpable, and typically benign testicular micro-nodules at ultrasonographic examination, representing Leydig cell hyperplasia or Leydig tumors. Increased LH levels raising from testicular damage might play a pivotal role by acting as growth factor for Leydig cells. To date, evidence on the efficacy of testosterone replacement therapy (TRT) on decreasing the micro-nodules volume are lacking...

ea0075d12 | Diabetes | EYES2021

Sex differences in quality of life and sexual function in type 2 diabetes mellitus: results from the RECOGITO trial

Feola Tiziana , Ferrari Davide , Pofi Riccardo , Lecis Claudio , Centello Roberta , Lenzi Andrea , Gianfrilli Daniele , Isidori Andrea M. , Giannetta Elisa

Background: Type 2 diabetes mellitus (T2DM) significantly impacts Health-Related Quality of Life (HRQoL) and sexual function. The aim of this study was to evaluate sex differences in HRQoL and sexual function in patients with T2DM.Methods: We performed an ancillary study of RECOGITO trial (REmodelling in Diabetic CardiOmyopathy: Gender Response to PDE5i InhibiTOrs - NCT01803828). All patients completed the 36-item-Short-Form Health Survey (SF-36), assess...

ea0081p280 | Adrenal and Cardiovascular Endocrinology | ECE2022

Coagulation parameters in asymptomatic patients with adrenal incidentaloma: is mild autonomous cortisol secretion correlated with thromboembolic risk?

Minnetti Marianna , Bonaventura Ilaria , Hasenmajer Valeria , De Alcubierre Dario , Tomaselli Alessandra , Ferrari Davide , Pofi Riccardo , Cozzolino Alessia , Sbardella Emilia , Lenzi Andrea , Isidori Andrea

Background: Overt hypercortisolism is highly associated with venous thromboembolism. Patients with Cushing’s syndrome (CS) typically show an alteration of the intrinsic coagulation pathway, especially an increase in factor VIII (f-VIII), and increased levels of coagulation inhibitors (i.e., antithrombin III) as a compensatory response. Mild autonomous cortisol secretion (MACS) has been variably associated with higher risk of cardiovascular events and mortality compared to...

ea0090p278 | Adrenal and Cardiovascular Endocrinology | ECE2023

Bone metabolism and dual-release Hydrocortisone: results from a real-life study

Ferrari Davide , Sada Valentina , Hasenmajer Valeria , De Alcubierre Dario , Puliani Giulia , Minnetti Marianna , Cozzolino Alessia , Bonaventura Ilaria , Tomaselli Alessandra , Pofi Riccardo , Lenzi Andrea , M. Isidori Andrea

Background: Patients with adrenal insufficiency (AI) require long-term glucocorticoid (GC) replacement therapy and generally show an increased prevalence of bone metabolism alterations. Only few data are available on bone safety of dual-release Hydrocortisone (DR-HC) therapy.Objective: To evaluate bone metabolism in both primary AI (PAI) and secondary AI (SAI) during long-term therapy with DR-HC.Methods: We studied patients with AI...

ea0090p555 | Adrenal and Cardiovascular Endocrinology | ECE2023

Coagulation parameters in patients with adrenal incidentalomas and mild cortisol secretion: sex difference matters

Bonaventura Ilaria , Minnetti Marianna , De Alcubierre Dario , Tomaselli Alessandra , Ferrari Davide , Sada Valentina , Angelini Francesco , Hasenmajer Valeria , Cozzolino Alessia , Sbardella Emilia , Pofi Riccardo , Lenzi Andrea , Isidori Andrea M.

Background: Patients with Cushing’s syndrome (CS) typically show an alteration in the intrinsic coagulation pathway, leading to an increased risk of venous thromboembolism. Cortisol autonomy has been variably associated with higher risk of cardiovascular events and mortality compared to patients with non-functioning adrenal adenomas (NFA), particularly in women younger than 65 years. However, dedicated studies describing coagulation status in patients with adrenal inciden...

ea0014p130 | (1) | ECE2007

Enhanced expression of functional P2X7 receptor in human papillary thyroid cancer

Dardano Angela , Ferrari Davide , Cuccato Sabina , Santini Eleonora , Caraccio Nadia , Gulinelli Sara , Callegari Giulia , Faviana Pinuccia , Solini Anna , Di Virgilio Francesco , Monzani Fabio

Extracellular ATP modulates several biological processes via activation of plasma membrane receptors (P2Rs) in normal human thyrocytes (NT). We characterized P2Rs expression and function in two thyroid cancer cell lines: FB1 (anaplastic cancer) and FB2 [papillary cancer (PTC)]. P2Rs expression was evaluated by RT-PCR and WB, intracellular Ca2+changes by fluorimetric technique (Fura2-AM), IL-6 release by ELISA, intracellular [i(ATP)] and extracellular ATP [...

ea0093oc3 | Oral communication 1: Adrenal Diseases | EYES2023

Preoperative 1 mg dexamethasone suppression test predicts hypothalamus–pituitary–adrenal axis recovery: A one-year retrospective study of adrenal incidentalomas undergoing unilateral adrenalectomy

Bonaventura Ilaria , Tomaselli Alessandra , Angelini Francesco , Ferrari Davide , De Alcubierre Dario , Sada Valentina , Minnetti Marianna , Hasenmajer Valeria , Cozzolino Alessia , Sbardella Emilia , Isidori Andrea , Pofi Riccardo

Background: The evaluation of postoperative adrenal insufficiency (PAI) and hypothalamus–pituitary–adrenal (HPA) axis recovery in patients with adrenal incidentaloma (AI) undergoing unilateral adrenalectomy remains limited.Objectives: We aimed to identify predictive factors for PAI development and evaluate HPA axis recovery in AI patients undergoing unilateral adrenalectomy.Methods: We retrospectively analysed adrenal fun...

ea0099ep182 | Adrenal and Cardiovascular Endocrinology | ECE2024

Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single centre study

Bonaventura Ilaria , Tomaselli Alessandra , Angelini Francesco , Ferrari Davide , De Alcubierre Dario , Hasenmajer Valeria , Sbardella Emilia , Cozzolino Alessia , Paganini Alessandro , Isidori Andrea , Minnetti Marianna , Pofi Riccardo

Background: Limited information exists on postoperative hypocortisolism and hypothalamuspituitary-adrenal axis recovery in patients with adrenal incidentaloma following unilateral adrenalectomy. We evaluated frequency of postoperative hypocortisolism and predictors for recovery in non-aldosterone- producing adrenocortical adenoma patients after unilateral adrenalectomy.Methods: A retrospective analysis of 32 adrenal incidentaloma patients originally incl...

ea0099ep293 | Reproductive and Developmental Endocrinology | ECE2024

Impact of drospirenone-only-pill on sexual function: experience of our‘pcos and female endocrinology outpatient clinic’

Tomaselli Alessandra , Minnetti Marianna , Rosato Elena , Tarantino Chiara , De Alcubierre Dario , Ferrari Davide , Rizzo Flavio , Sciarra Francesca , Pofi Riccardo , Isidori Andrea , Pozza Carlotta

Introduction and Objectives of the Study: Combined oral contraceptives (COCs) are frequently prescribed for fertility control, however sexual dysfunction has been reported as a common side effect. In 2020, a novel progestin-only pill containing Drospirenone (DRSP) was approved as an oral contraceptive. To date, here is a notable dearth of data on the impact of DRSP on sexual function and impact on hormones, particularly regarding steroids. This study aims to investigate the po...